Michael Chen

Michael Chen is a senior financial analyst and investment researcher with over 15 years of experience covering global equity markets. He specializes in technology sector analysis, fundamental valuation, and macroeconomic trends affecting institutional portfolios.

Equity ResearchFinancial ModelingSEC Filings AnalysisTechnology StocksMacroeconomic AnalysisValuation MethodsEarnings AnalysisRisk AssessmentPortfolio ManagementESG Investing

219 published articles • Page 6

Articles by Michael Chen

QBTS Stock Pre-Market Rally: What Drove It and How to Verify the Catalyst

QBTS Stock Pre-Market Rally: What Drove It and How to Verify the Catalyst

A filing-first breakdown of D-Wave’s Jan 27 updates—and a checklist for separating headlines from fundamentals

Richtech Robotics’ Microsoft Tie-Up: What Drove the RR Spike

Richtech Robotics’ Microsoft Tie-Up: What Drove the RR Spike

A practical breakdown of the ADAM + Azure AI collaboration, what it does, and how to monitor follow-on filings and risk disclosures

NTLA stock jump: what the FDA clinical hold lift means

NTLA stock jump: what the FDA clinical hold lift means

A practical explainer of Intellia’s MAGNITUDE-2 update, the key risks to track next, and how to monitor trial and regulatory signals in Alpha Analyst

Amazon Fresh and Amazon Go Closures: Investor Research Playbook

Amazon Fresh and Amazon Go Closures: Investor Research Playbook

What the Whole Foods expansion signals, what to verify in filings, and how to monitor next steps in Alpha Analyst

Tesla brand value drop in 2025: What it signals for investors

Tesla brand value drop in 2025: What it signals for investors

How to turn a headline about brand perception into a repeatable monitoring workflow

IonQ–SkyWater deal: what was announced and how to research it

IonQ–SkyWater deal: what was announced and how to research it

A practical M&A-read checklist, key terms to track, and an Alpha Analyst workflow for staying ahead of the filings

Tesla autonomy and Robotaxi: how to research the “pivotal year” narrative

Tesla autonomy and Robotaxi: how to research the “pivotal year” narrative

Turn analyst commentary into a repeatable diligence workflow for TSLA’s self-driving roadmap, disclosures, and near-term catalysts

MNKD stock jump explained: Afrezza label update and what to watch next

MNKD stock jump explained: Afrezza label update and what to watch next

A practical catalyst breakdown for MannKind investors, plus a workflow to track FDA-driven moves in Alpha Analyst

IBRX Volatility: How to Read “Median OS Not Reached” Updates

IBRX Volatility: How to Read “Median OS Not Reached” Updates

A biotech catalyst checklist using ImmunityBio’s glioblastoma Phase 2 headline as a case study